Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Life Sciences and Healthcare
March 3, 2020
Life Sciences and Healthcare
February 29, 2020
Life Sciences and Healthcare
February 28, 2020
Intellectual Property
February 27, 2020
Life Sciences and Healthcare
February 12, 2020